Main Sequence

Main Sequence is Australia’s premier deep tech investment fund, dedicated to turning groundbreaking scientific discoveries into the industries of tomorrow. Focused on addressing the world’s most pressing challenges, Main Sequence collaborates closely with scientists, researchers, and industry partners to create, fund, and accelerate innovative companies. With a strong commitment to fostering a more prosperous future for humanity, Main Sequence leverages its expertise to drive transformative change.

Located at Level 5, 13 Garden St, Eveleigh, NSW 2015, AU, Main Sequence has a proven track record of investing in companies that are revolutionizing healthcare, food production, connectivity, and more. Established in 2017 to manage the CSIRO Innovation Fund, Main Sequence continues to build on its legacy of reinvesting in future successes. Their strategic investments have spurred numerous collaborative projects between companies and universities, as well as significant partnerships with CSIRO, driving innovation and growth.

Main Sequence is committed to supporting and accelerating the development of deep tech ventures. The firm's dedication to innovation and strategic investment makes it a key player in the venture capital and private equity landscape. We invite the management team at Main Sequence to create a customized and exclusive company showcase and product listing on our platform to further enhance their visibility and commercial development.